- Research Article
In Vitro evaluation of the cytotoxic and anti-proliferative properties of resveratrol and several of its analogs
Cellular & Molecular Biology Letters volume 13, pages 553–569 (2008)
Resveratrol (RES), a component of red wine, possesses anti-inflammatory properties. The studies described in the present work were aimed at evaluating the potential for RES and related stilbene analogs (piceatannol, PIC; pterostilbene, TPS; trans-stilbene, TS; and trans-stilbene oxide, TSO) to exhibit toxicity towards RAW 264.7 mouse macrophages. The effect of TS, TSO, RES and TPS on RAW 264.7 macrophage viability was determined by two standard methods: (a) the MTT assay and (b) the trypan blue dye exclusion test. Whereas macrophages were more sensitive to PIC (LC50 trypan ∼ 1.3 μM) and to TPS (LC50 trypan ∼ 4.0 μM and LC50 MTT ∼ 8.3 μM) than to RES (LC50 trypan ∼ 8.9 μM and LC50 MTT ∼ 29.0 μM), they were relatively resistant to TSO (LC50 trypan ∼ 61.0 μM and LC50 MTT > 100 μM) and to TS (LC50 trypan ≥ 5.0 μM and LC50 MTT ≥ 5.0 μM). The ability of selected stilbenes (RES, TPS and PIC) to exhibit growth inhibitory effects was also examined. Although RES and TPS were observed to inhibit cell proliferation in macrophages (IC50 ≤ 25 μM), these cells were resistant to growth inhibition by PIC (IC50 ≥ 50 μM). The data obtained in the present analysis demonstrate that substituted stilbene compounds such as RES have the capacity to exhibit cytotoxic and anti-proliferative activities in macrophages.
Howard, A., Chopra, M., Thurnham, D., Strain, J., Fuhrman, B. and Aviram, M. Red wine consumption and inhibition of LDL oxidation: What are the important components? Med. Hypotheses 59 (2002) 101–104.
Ray, P.S., Maulik, G., Cordis, G.A., Bertelli, A.A., Bertelli, A. and Das, D.K. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free. Radic. Biol. Med. 27 (1999) 160–169.
Hung, L.M., Chen, J.K., Huang, S.S., Lee, R.S. and Su, M.J. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc. Res. 47 (2000) 549–555.
Mokni, M., Limam, F., Elkahoui, S., Amri, M. and Aouani, E. Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury. Arch. Biochem. Biophys. 457 (2007) 1–6.
Constant, J. Alcohol, ischemic heart disease, and the French paradox. Coron. Artery Dis. 8 (1997) 645–649.
Jang, D.S., Kang, B.S., Ryu, S.Y., Chang, I.M., Min, K.R. and Kim, Y. Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production. Biochem. Pharmacol. 57 (1999) 705–712.
Cao, Z. and Li, Y. Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur. J. Pharmacol. 489 (2004) 39–48.
Murias, M., Handler, N., Erker, T., Pleban, K., Ecker, G., Saiko, P., Szekeres, T. and Jager, W. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg. Med. Chem. 12 (2004) 5571–5578.
Pervaiz, S. Resveratrol: from grapevines to mammalian biology. FASEB J. 17 (2003) 1975–1985.
Jeandet, P., Douillet-Breuil, A.C., Bessis, R., Debord, S., Sbaghi, M. and Adrian, M. Phytoalexins from the vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolism. J. Agric. Food Chem. 50 (2002) 2731–2741.
Murias, M., Jager, W., Handler, N., Erker, T., Horvath, Z., Szekeres, T., Nohl, H. and Gille, L. Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochem. Pharmacol. 69 (2005) 903–912.
Kageura, T., Matsuda, H., Morikawa, T., Toguchida, I., Harima, S., Oda, M. and Yoshikawa, M. Inhibitors from rhubarb on lipopolysaccharide-induced nitric oxide production in macrophages: structural requirements of stilbenes for the activity. Bioorg. Med. Chem. 9 (2001) 1887–1893.
Rimando, A.M., Cuendet, M., Desmarchelier, C., Mehta, R.G., Pezzuto, J.M. and Duke, S.O. Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J. Agric. Food Chem. 50 (2002) 3453–3457.
Tolomeo, M., Grimaudo, S., Di Cristina, A., Roberti, M., Pizzirani, D., Meli, M., Dusonchet, L., Gebbia, N., Abbadessa, V., Crosta, L., Barucchello, R., Grisolia, G., Invidiata, F. and Simoni, D. Pterostilbene and 3′-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. Int. J. Biochem. Cell Biol. 37 (2005) 1709–1726.
Wolter, F., Clausnitzer, A., Akoglu, B. and Stein, J. Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines. J. Nutr. 132 (2002) 298–302.
Larrosa, M., Tomas-Barberan, F.A. and Espin, JC. Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells. J. Agric. Food Chem. 51 (2003) 4576–4584.
Wieder, T., Prokop, A., Bagci, B., Essmann, F., Bernicke, D., Schulze-Osthoff, K., Dorken, B., Schmalz, H. G., Daniel, P. T. and Henze, G. Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts. Leukemia 15 (2001) 1735–1742.
Radkar, V., Hardej, D., Lau-Cam, C. and Billack, B. Evaluation of resveratrol and piceatannol cytotoxicity in macrophages, T cells, and skin cells. Arh. Hig. Rada. Toksikol. 58 (2007) 293–304.
Crowell, J.A., Korytko, P.J., Morrissey, R.L., Booth, T.D. and Levine, B.S. Resveratrol-associated renal toxicity. Toxicol. Sci. 82 (2004) 614–619.
Ferry-Dumazet, H., Garnier, O., Mamani-Matsuda, M., Vercauteren, J., Belloc, F., Billiard, C., Dupouy, M., Thiolat, D., Kolb, J. P., Marit, G., Reiffers, J. and Mossalayi, M. D. Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 23 (2002) 1327–1333.
Azmi, A.S., Bhat, S.H., Hanif, S. and Hadi, S.M. Plant polyphenols mobilize endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for anticancer properties. FEBS Lett. 580 (2006) 533–538.
Hebbar, V., Shen, G., Hu, R., Kim, B.R., Chen, C., Korytko, P.J., Crowell, J.A., Levine, B.S. and Kong, A.N. Toxicogenomics of resveratrol in rat liver. Life Sci. 76 (2005) 2299–2314.
Schmitt, E., Lehmann, L., Metzler, M. and Stopper, H. Hormonal and genotoxic activity of resveratrol. Toxicol. Lett. 136 (2002) 133–142.
Djoko, B., Chiou, R.Y., Shee, J.J. and Liu, Y.W. Characterization of immunological activities of peanut stilbenoids, arachidin-1, piceatannol, and resveratrol on lipopolysaccharide-induced inflammation of RAW 264.7 macrophages. J. Agric. Food Chem. 55 (2007) 2376–2383.
Sanoh, S., Kitamura, S., Sugihara, K. and Ohta, S. Cytochrome P450 1A1/2 mediated metabolism of trans-stilbene in rats and humans. Biol. Pharm. Bull. 25 (2002) 397–400.
Sanoh, S., Kitamura, S., Sugihara, K., Kohta, R., Ohta, S. and Watanabe, H. Effects of stilbene and related compounds on reproductive organs in B6C3F1/Crj mouse. J. Health Sci. 52 (2006) 613–622.
Grohs, B.M. and Kunz, B. Fungitoxicity of chemical analogs with heartwood toxins. Curr. Microbiol. 37 (1998) 67–69.
Meijer, J., DePierre, J.W., Wang, P.P. and Guengerich, F.P. Purification and characterization of the major microsomal cytochrome P-450 form induced by trans-stilbene oxide in rat liver. Biochim. Biophys. Acta. 789 (1984) 1–9.
Bucker, M., Golan, M., Schmassmann, H.U., Glatt, H.R., Stasiecki, P. and Oesch, F. The epoxide hydratase inducer trans-stilbene oxide shifts the metabolic epoxidation of benzo(a)pyrene from the bay-to the K-region and reduces its mutagenicity. Mol. Pharmacol. 16 (1979) 656–666.
Williams, J.B., Wang, R., Lu, A.Y. and Pickett, C.B. Rat liver DT-diaphorase: Regulation of functional mRNA levels by 3-methylcholanthrene, trans-stilbene oxide, and phenobarbital. Arch. Biochem. Biophys. 232 (1984) 408–413.
Raschke, W.C., Baird, S., Ralph, P. and Nakoinz, I. Functional macrophage cell lines transformed by abelson leukemia virus. Cell 15 (1978) 261–267.
Giard, D.J., Aaronson, S.A., Todaro, G.J., Arnstein, P., Kersey, J.H., Dosik, H. and Parks, W.P. In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51 (1973) 1417–1423.
Lorenz, E., Patel, D.D., Hartung, T. and Schwartz, D.A. Toll-like receptor 4 (TLR4)-deficient murine macrophage cell line as an in vitro assay system to show TLR4-independent signaling of bacteroides fragilis lipopolysaccharide. Infect. Immun. 70 (2002) 4892–4896.
Foley, G.E., Lazarus, H., Farber, S., Uzman, B.G., Boone, B.A and McCarthy, RE. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18 (1965) 522–529.
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55–63.
Shah, Y.M., Al-Dhaheri, M., Dong, Y., Ip, C., Jones, F.E. and Rowan, B.G. Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells. Mol. Cancer Ther. 4 (2005) 1239–1249.
Bruggisser, R., von Daeniken, K., Jundt, G., Schaffner, W. and Tullberg-Reinert, H. Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay. Planta Med. 68 (2002) 445–448.
Ovesna, Z., Kozics, K., Bader, Y., Saiko, P., Handler, N., Erker, T. and Szekeres, T. Antioxidant activity of resveratrol, piceatannol and 3,3′,4,4′,5,5′-hexahydroxy-trans-stilbene in three leukemia cell lines. Oncol. Rep. 16 (2006) 617–624.
Potter, G.A., Patterson, L.H., Wanogho, E., Perry, P.J., Butler, P.C., Ijaz, T., Ruparelia, K.C., Lamb, J.H., Farmer, P.B., Stanley, L.A. and Burke, M.D. The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br. J. Cancer 86 (2002) 774–778.
Piver, B., Fer, M., Vitrac, X., Merillon, J.M., Dreano, Y., Berthou, F. and Lucas, D. Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochem. Pharmacol. 68 (2004) 773–782.
Zheng, L.F., Wei, Q.Y., Cai, Y.J., Fang, J.G., Zhou, B., Yang, L. and Liu, Z.L. DNA damage induced by resveratrol and its synthetic analogues in the presence of cu (II) ions: mechanism and structure-activity relationship. Free Radic. Biol. Med. 41 (2006) 1807–1816.
Huang, X.F., Ruan, B.F., Wang, X.T., Xu, C., Ge, H.M., Zhu, H.L. and Tan, R.X. Synthesis and cytotoxic evaluation of a series of resveratrol derivatives modified in C2 position. Eur. J. Med. Chem. 42 (2007) 263–267.
Roberti, M., Pizzirani, D., Simoni, D., Rondanin, R., Baruchello, R., Bonora, C., Buscemi, F., Grimaudo, S. and Tolomeo, M. Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. J. Med. Chem. 46 (2003) 3546–3554.
Matsuoka, A., Takeshita, K., Furuta, A., Ozaki, M., Fukuhara, K. and Miyata, N. The 4′-hydroxy group is responsible for the in vitro cytogenetic activity of resveratrol. Mutat. Res. 521(2002) 29–35.
Fukuhara, K., Nagakawa, M., Nakanishi, I., Ohkubo, K., Imai, K., Urano, S., Fukuzumi, S., Ozawa, T., Ikota, N., Mochizuki, M., Miyata, N. and Okuda, H. Structural basis for DNA-cleaving activity of resveratrol in the presence of cu(II). Bioorg. Med. Chem. 14 (2006) 1437–1443.
Cadenas, E. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem. Pharmacol. 49 (1995) 127–140.
Galati, G. and O’Brien, P.J. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Rad. Biol. Med. 37 (2004) 287–303.
Bernhard, D., Tinhofer, I., Tonko, M., Hubl, H., Ausserlechner, M.J., Greil, R., Kofler, R. and Csordas, A. Resveratrol causes arrest in the S-phase prior to fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ. 7 (2000) 834–842.
Tsan, M.F., White, J.E., Maheshwari, J.G. and Chikkappa, G. Anti-leukemia effect of resveratrol. Leuk. Lymphoma 43 (2002) 983–987.
Zunino, S.J. and Storms, D. H. Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore. Cancer Lett. 240 (2006) 123–134.
Wu, S.L., Yu, L., Pan, C.E., Jiao, X.Y., Lv, Y., Fu, J. and Meng, K.W. Apoptosis of lymphocytes in allograft in a rat liver transplantation model induced by resveratrol. Pharmacol. Res. 54 (2006) 19–23.
Mizutani, K., Ikeda, K., Kawai, Y. and Yamori, Y. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 253 (1998) 859–863.
Dai, Z., Li, Y., Quarles, L.D., Song, T., Pan, W., Zhou, H. and Xiao, Z. Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomed. 14 (2007) 806–814.
Inoue, K. and Creveling, C.R. Immunocytochemical localization of catechol-O-methyltransferase in the oviduct and in macrophages in corpora lutea of rat. Cell Tissue Res. 245 (1986) 623–628.
About this article
Cite this article
Billack, B., Radkar, V. & Adiabouah, C. In Vitro evaluation of the cytotoxic and anti-proliferative properties of resveratrol and several of its analogs. Cell Mol Biol Lett 13, 553–569 (2008). https://doi.org/10.2478/s11658-008-0022-9
- Cell viability
- Cell proliferation
- TLR4 (−/−)